These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 10835699)

  • 21. [The role of the selective blocking of angiotensin II receptors in the treatment of cardiovascular diseases].
    Carnovali M
    Clin Ter; 2001; 152(2):103-6. PubMed ID: 11441521
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic clamping of renin gene expression induces hypertension and elevation of intrarenal Ang II levels of graded severity in Cyp1a1-Ren2 transgenic rats.
    Mitchell KD; Bagatell SJ; Miller CS; Mouton CR; Seth DM; Mullins JJ
    J Renin Angiotensin Aldosterone Syst; 2006 Jun; 7(2):74-86. PubMed ID: 17083061
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Continuous inhibition of the renin-angiotensin system and protection from hypertensive end-organ damage by brief treatment with angiotensin II type 1 receptor blocker in stroke-prone spontaneously hypertensive rats.
    Takemori K; Ishida H; Ito H
    Life Sci; 2005 Sep; 77(18):2233-45. PubMed ID: 15963533
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Tissue consequence of renin-angiotensin system activation].
    Michel JB
    Bull Acad Natl Med; 2004; 188(4):611-9; discussion 620. PubMed ID: 15587680
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Renal volume, renin-angiotensin-aldosterone system, hypertension, and left ventricular hypertrophy in patients with autosomal dominant polycystic kidney disease.
    Schrier RW
    J Am Soc Nephrol; 2009 Sep; 20(9):1888-93. PubMed ID: 19696226
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Is hypertension a disease of the intra-renal renin-angiotensin system?].
    Ménard J
    Bull Acad Natl Med; 2004; 188(4):661-4; discussion 664-5. PubMed ID: 15587685
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Working outside the system: an update on the unconventional behavior of the renin-angiotensin system components.
    Kurdi M; De Mello WC; Booz GW
    Int J Biochem Cell Biol; 2005 Jul; 37(7):1357-67. PubMed ID: 15833268
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Critical role for p47phox in renin-angiotensin system activation and blood pressure regulation.
    Grote K; Ortmann M; Salguero G; Doerries C; Landmesser U; Luchtefeld M; Brandes RP; Gwinner W; Tschernig T; Brabant EG; Klos A; Schaefer A; Drexler H; Schieffer B
    Cardiovasc Res; 2006 Aug; 71(3):596-605. PubMed ID: 16843452
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
    Weir MR
    Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The kidney and hypertension: over 70 years of research.
    Campese VM; Park J
    J Nephrol; 2006; 19(6):691-8. PubMed ID: 17173239
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evolution of renin.
    Peart WS
    Hypertension; 1991 Nov; 18(5 Suppl):III100-8. PubMed ID: 1843850
    [TBL] [Abstract][Full Text] [Related]  

  • 32. How to explain the differences between renin angiotensin system modulators.
    Levy BI
    Am J Hypertens; 2005 Sep; 18(9 Pt 2):134S-141S. PubMed ID: 16125050
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sodium sensitive hypertension: renal and adrenal non-modulation in its pathogenesis.
    Hollenberg NK; Williams GH
    Kidney; 1988 Nov; 21(3):13-8. PubMed ID: 11538850
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of the renin-angiotensin-aldosterone system in diabetes and its vascular complications.
    Cooper ME
    Am J Hypertens; 2004 Nov; 17(11 Pt 2):16S-20S; quiz A2-4. PubMed ID: 15539106
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Angiotensin converting enzyme inhibition and dihydropyridine calcium channel blockade in the treatment of left ventricular hypertrophy in arterial hypertension.
    Palmieri V; Devereux RB
    Minerva Cardioangiol; 2002 Jun; 50(3):169-74. PubMed ID: 12107398
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Renin inhibition: what are the clinical perspectives?
    Hollenberg NK
    Semin Nephrol; 2007 Sep; 27(5):511-8. PubMed ID: 17868787
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Renin: from 'pro' to promoter.
    Morris BJ
    Bioessays; 2003 May; 25(5):520-7. PubMed ID: 12717823
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of high salt intake on local renin-angiotensin system and ventricular dysfunction following myocardial infarction in rats.
    de Resende MM; Mill JG
    Clin Exp Pharmacol Physiol; 2007 Apr; 34(4):274-9. PubMed ID: 17324137
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mast cells: the missing source of cardiac renin?
    Xiao HD; Bernstein KE
    Mol Interv; 2005 Feb; 5(1):11-4. PubMed ID: 15731500
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Renin inhibition in hypertension.
    Gradman AH; Kad R
    J Am Coll Cardiol; 2008 Feb; 51(5):519-28. PubMed ID: 18237679
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.